In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

Mayo Clinic researchers report that a highly targeted, noninvasive form of radiation therapy reduced episodes of a ...

Adagio Medical Holdings, Inc. ADGM shares are up during Monday’s premarket session following the announcement of positive ...

The trial is evaluating the vCLAS cryoablation system at 20 centres across Canada and the US.

Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...

MARQUETTE, Mich. (WLUC) - Physical Medicine & Rehabilitation Physician Eric Sturos stopped by the TV6 Morning News to explain the process of the Intracept procedure. Sturos says the Intracept ...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...

At Johns Hopkins in Baltimore, cardiologists are road-testing a patient-specific "digital twin" of a diseased heart, a computer model used to plan and guide catheter ablation for a dangerous rhythm ...

Virtual replicas of individual patients’ hearts have allowed doctors to refine and personalize a lifesaving medical procedure for dangerous rhythm disturbances. Heart models may be just the leading ...

Working with "digital twins" of patients' hearts, doctors improved cardiac ablation outcomes for patients with life-threatening arrythmias. In the first clinical trials for cardiac digital twins ...

In a 10-patient feasibility study, heart digital twins were used to guide VT ablation. Afterward, VT was noninducible in all patients; at a mean follow-up of 13 months, 8 patients were free of ...

Catheter ablation has been shown to improve prognosis in patients with heart failure (HF) and atrial fibrillation (AF); however, the optimal ablation strategy remains undefined. At 36 months, the ...